|
Greetings!
Giving Thanks Throughout the Year
It's that time of year again, where we all stop and take time to think about the many things we are grateful for in our lives. For many of us, our thanks begin with our family and friends with whom we share our good will and fortune. On behalf of the Scleroderma Foundation, we'd like to thank all members of the scleroderma community for supporting one another as well as the mission of the organization.
Please note that our offices will be closed on Thursday, November 25th and Friday, November 26th, in observance of the Thanksgiving holiday. |
|
Participate in a
Research Interview |
|
Have you been diagnosed with systemic sclerosis, scleroderma, or CREST? Do you currently have at least one digital ulcer on your hand?
If you answered "yes" to both questions and you live in the US, then you could be eligible to take part in an interview study and be paid for your time and participation. Click here for more information. 
|
|
Update on Pulmonary
Arterial Hypertension |
Click here to view an interview with Andrew F. Shorr, MD, MPH and Chee M. Chan, MD. from the 2010 Annual American College of Chest Physicians meeting. |
| A Report from American College of Rheumatology - Drug Potent in Raynaud's Phenonmenon |
By John Gever, Senior Editor, MedPage Today
Published: November 10, 2010
Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planner
ATLANTA -- A drug developed to help men overcome erectile dysfunction appears to successfully heal finger ulcers associated with Raynaud's phenomenon -- mainly among women.
Note that this study was published as an abstract and presented at the ACR conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal. |
|
New ANA Testing Does Not Diagnose Disorder in 40% of Scleroderma Patients |
New research from Georgetown University Medical Center suggests that up to 40 percent of scleroderma patients will not be correctly diagnosed with the disorder using a new automated commercial screening test. The findings of the study were presented Wednesday, November 10th at the Annual Scientific Meeting of the American College of Rheumatology in Atlanta, Georgia.
|
